- Home
- ENS vs CRNX Comparison
ENS vs CRNX Comparison
Compare ENS & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENS
- CRNX
- Stock Information
- Founded
- ENS 1991
- CRNX 2008
- Country
- ENS United States
- CRNX United States
- Employees
- ENS N/A
- CRNX N/A
- Industry
- ENS Industrial Machinery/Components
- CRNX Biotechnology: Pharmaceutical Preparations
- Sector
- ENS Technology
- CRNX Health Care
- Exchange
- ENS Nasdaq
- CRNX Nasdaq
- Market Cap
- ENS 3.3B
- CRNX 2.8B
- IPO Year
- ENS N/A
- CRNX 2018
- Fundamental
- Price
- ENS $83.18
- CRNX $30.16
- Analyst Decision
- ENS Strong Buy
- CRNX Strong Buy
- Analyst Count
- ENS 2
- CRNX 10
- Target Price
- ENS $117.50
- CRNX $75.00
- AVG Volume (30 Days)
- ENS 635.5K
- CRNX 676.7K
- Earning Date
- ENS 08-06-2025
- CRNX 08-07-2025
- Dividend Yield
- ENS 1.16%
- CRNX N/A
- EPS Growth
- ENS 38.31
- CRNX N/A
- EPS
- ENS 8.99
- CRNX N/A
- Revenue
- ENS $3,617,579,000.00
- CRNX $760,000.00
- Revenue This Year
- ENS $2.47
- CRNX $402.12
- Revenue Next Year
- ENS $3.32
- CRNX $770.88
- P/E Ratio
- ENS $9.23
- CRNX N/A
- Revenue Growth
- ENS 1.00
- CRNX N/A
- 52 Week Low
- ENS $76.57
- CRNX $24.10
- 52 Week High
- ENS $112.53
- CRNX $62.53
- Technical
- Relative Strength Index (RSI)
- ENS 39.23
- CRNX 41.11
- Support Level
- ENS $85.95
- CRNX $32.05
- Resistance Level
- ENS $88.07
- CRNX $31.56
- Average True Range (ATR)
- ENS 1.81
- CRNX 1.08
- MACD
- ENS -0.28
- CRNX -0.18
- Stochastic Oscillator
- ENS 15.28
- CRNX 5.25
About ENS EnerSys
EnerSys provides stored energy solutions for industrial applications. It also manufactures and distributes energy systems solutions and motive power batteries, specialty batteries, battery chargers, power equipment, battery accessories, and outdoor equipment enclosure solutions to customers. Energy Systems that combine enclosures, power conversion, power distribution, and energy storage are used in the telecommunication and broadband, utility industries, uninterruptible power supplies, and numerous applications requiring stored energy solutions. Its segments include Energy Systems, Motive Power, and Specialty.
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.